title: Phase 1 clinical trials: not just for safety anymore?
authors.forename: Janardan
authors.initials: J
authors.lastname: Khandekar
authors.forename: Melin
authors.initials: M
authors.lastname: Khandekar
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents